{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Noonan syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_methylphenidate",
          "name": "Methylphenidate"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_growth_hormone",
          "name": "Growth Hormone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_etoricoxib",
          "name": "Etoricoxib"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_tamoxifen",
          "name": "Tamoxifen"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_allopurinol",
          "name": "Allopurinol"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_angiotensin_ii_receptor_blockers",
          "name": "Angiotensin II Receptor Blockers"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_antiepileptics",
          "name": "Antiepileptics"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_propranolol",
          "name": "Propranolol"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_clonidine",
          "name": "Clonidine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_methylphenidate",
          "type": "Drug",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_growth_hormone",
          "type": "Drug",
          "label": "Growth Hormone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etoricoxib",
          "type": "Drug",
          "label": "Etoricoxib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tamoxifen",
          "type": "Drug",
          "label": "Tamoxifen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_allopurinol",
          "type": "Drug",
          "label": "Allopurinol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_angiotensin_ii_receptor_blockers",
          "type": "Drug",
          "label": "Angiotensin II Receptor Blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_antiepileptics",
          "type": "Drug",
          "label": "Antiepileptics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_propranolol",
          "type": "Drug",
          "label": "Propranolol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_clonidine",
          "type": "Drug",
          "label": "Clonidine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_noonan_syndrome",
          "type": "Disease",
          "label": "Noonan Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_growth_factor",
          "type": "Target",
          "label": "Growth Factor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_growth_regulation",
          "type": "Pathway",
          "label": "Growth Regulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_developmental_disorder",
          "type": "Phenotype",
          "label": "Developmental Disorder",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_growth_hormone",
          "target": "target_growth_factor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "促进生长因子活性"
        },
        {
          "source": "drug_growth_hormone",
          "target": "pathway_growth_regulation",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "生长激素涉及生长调节途径"
        },
        {
          "source": "pathway_growth_regulation",
          "target": "d_noonan_syndrome",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "生长调节途径与Noonan综合症相关"
        },
        {
          "source": "drug_growth_hormone",
          "target": "H1",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "支持生长激素可能影响 Noonan 综合症"
        },
        {
          "source": "drug_methylphenidate",
          "target": "phenotype_developmental_disorder",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "有助于注意力和行为问题"
        },
        {
          "source": "drug_beta_blockers",
          "target": "d_noonan_syndrome",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "可用于治疗心血管症状"
        },
        {
          "source": "drug_aspirin",
          "target": "phenotype_developmental_disorder",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "部分病例改善"
        },
        {
          "source": "drug_etoricoxib",
          "target": "d_noonan_syndrome",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能影响血管问题"
        },
        {
          "source": "drug_tamoxifen",
          "target": "d_noonan_syndrome",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能影响某些相关病理"
        },
        {
          "source": "drug_allopurinol",
          "target": "phenotype_developmental_disorder",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "临床观察数据不确定"
        },
        {
          "source": "drug_angiotensin_ii_receptor_blockers",
          "target": "d_noonan_syndrome",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "可能改善心血管状况"
        },
        {
          "source": "drug_propranolol",
          "target": "d_noonan_syndrome",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "常用于心血管症状"
        },
        {
          "source": "drug_clonidine",
          "target": "d_noonan_syndrome",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "潜在用药选项"
        },
        {
          "source": "drug_antiepileptics",
          "target": "phenotype_developmental_disorder",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能用于治疗癫痫相关症状"
        },
        {
          "source": "drug_beta_blockers",
          "target": "target_growth_factor",
          "relation": "inhibits",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "可能影响生长因子活性"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "生长激素对 Noonan 综合症有潜在的积极影响",
        "confidence": "medium"
      },
      {
        "id": "C2",
        "text": "各种药物可能通过不同机制影响 Noonan 综合症",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "假设药物能够有效地到达靶组织并产生作用"
    ],
    "uncertainties": [
      "药物的具体机制及其安全性需进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需要进一步验证其他药物与 Noonan 综合症的关联路径？"
    ]
  }
}